FY25 FDA Broad Agency Announcement – Q&A Session
FY25 FDA Broad Agency Announcement – Question and Answer Session
Related Articles
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma
This phase 1b/2 nonrandomized clinical trial evaluates whether equecabtagene autoleucel can benefit patients with relapsed or refractory multiple myeloma and determines the overall response rate…
OB756 Showcases Favorable Tolerability in JAK Inhibitor–Naive Myelofibrosis
An investigative JAK2 inhibitor demonstrated acceptable tolerability and early clinical activity in patients with JAK inhibitor–naive myelofibrosis.
Diagnostic radiology & CT course
This course is designed to provide in-depth academic teaching of the scientific principles underpinning x-ray and CT imaging, including descriptions of the imaging components,
Image theory, perception and processing course
This is a one-day course which covers the underpinning mathematics of medical imaging, comprising image formation, image processing techniques, human visual perception and image display…
Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling
Nature Cancer – Trumpp and colleagues develop a method to obtain long-term circulating tumor cell-derived organoids from individuals with metastatic breast cancer and identify the…
Postoperative Radiation Therapy Improves HRQOL, Safety in Early-Stage HR+/HER2– Breast Cancer
Radiation therapy produced superior HRQOL outcomes and fewer toxicities vs endocrine therapy in older patients with stage I luminal-like breast cancer.
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
CMG901 showed a manageable safety profile and had promising antitumour activity in patients with advanced gastric or gastro-oesophageal junction cancer.
Haematologist recognised in New Year Honours
A paediatric haematologist has been made a Member of the Order of the British Empire (MBE) in this year’s New Year Honours. Professor Ajay Vora,…
FDA Broad Agency Announcement: Frequently Asked Questions for Oncology
FDA Broad Agency Announcement: Frequently Asked Questions for Oncology Researchers
The potential role of AI in diagnosing melanoma and other skin cancers
Harald Kittler, MD, Medical University of Vienna, Vienna, Austria, discusses using artificial intelligence (AI) to diagnose skin cancers. Dermoscopic and clinical images provide ideal image-based…
